Company news

TiumBio Co., Ltd. news in 2025

TiumBio Co., Ltd.'s news releases, calls and decks from 2025, newest first.

View company

TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids

May 7, 2025

TiumBio's Partner Hansoh Pharma Expands Indications for Merigolix (HS-10518) with Initiation of ART (Assisted Reproductive Technology) Development

March 20, 2025